Workshop summary: Fetal growth: Its regulation and disorders

Pediatrics

Volumn 99, Issue 4, 1997, Pages 585-591

  Hay Jr , William W ^a,b   Catz, Charlotte S ^a,c   Grave, Gilman D ^a,b   Yaffe, Sumner J ^a,b  

^a Children's Hospital Colorado   (United States)

^b Nutrition and Growth ^*  (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; CYTOKINE; GROWTH HORMONE; HUMAN PLACENTA LACTOGEN; INTERLEUKIN 1; INTERLEUKIN 6; RETINOIC ACID; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; THYROID HORMONE;

ANIMAL MODEL; FETUS; FETUS DEVELOPMENT; FETUS GROWTH; GESTATIONAL AGE; GROWTH REGULATION; HORMONAL THERAPY; HUMAN; INTRAUTERINE GROWTH RETARDATION; NONHUMAN; NUTRITIONAL SUPPORT; PLACENTA; PREMATURITY; PRIORITY JOURNAL; REVIEW;

EID: 0030946642     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.99.4.585     Document Type: Review

References (70)

1. Lubchenco LO, Searls DT, Brazie JV. Neonatal mortality rate: relationship to birth weight and gestational age J Pediatr. 1972;81:814-822
2. Lubchenco LO. The High Risk Infant. Philadelphia, PA: WB Saunders; 1976
3. Thureen PJ, Trembler KA, Meschia G, Makowski EL, Wilkening RB. Placental glucose transport in heat induced fetal growth retardation. Am I Physiol 1992;263:R578-R585
4. Marconi AM, Cetin I, Davoli E, et al. An evaluation of fetal gluconeogenesis in intrauterine growth retarded pregnancies. Metabolism. 1993; 42:860-864
5. Molina RD, Meschia G, Battaglia FC, Hay WW Jr. Gestational maturation of placental glucose transfer capacity in sheep. Am J Physiol. 1991; 261:R697-R704
6. Carver TD, Quick AN Jr, Teng CC, et al. Leucine metabolism in chronically hypoglycémie hypoinsulinemic growth-restricted fetal sheep. Am J Physiol. 1997;272:E107-E117
7. Ross JC, Fennessey PV, Wilkening RB, Battaglia FC, Meschia G. Placental transport and fetal utilization of leucine in a model of fetal growth retardation. Am J Physiol. 1996;270:E491-E503
8. Milley JR. Effects of insulin on ovine fetal leucine kinetics and protein metabolism J Clin Invest. 1994;93:1616-1624
9. Townsend SF, Briggs KK, Carver TD, Hay WW Jr, Wilkening RB. Altered fetal liver and kidney insulin-like growth factor II mRNA in the sheep after chronic maternal glucose or nutrient deprivation. Clin Res. 1992;40:91A
10. Das UG, Schroeder RE, Hay WW Jr, Devaskar SU. Chronic hypoglycemia causes time-dependent and tissue-specific changes in ovine fetal GLUT-1 and GLUT-4 proteins. Pediatr Res. 1993;37:60A. Abstract 347
11. Barker DJP. Fetal and Infant Origins of Adult Disease. London, England: British Medical Journal; 1993
12. Snoeck A, Remade C, Reusens B, Hoet J J Effect of a low protein diet during pregnancy on the fetal rat endocrine pancreas. Biol Neonate. 1990;57:107-118
13. Dahri S, Snoeck A, Reusens B, Remacle C, Hoet JJ. Islet function in offspring of mothers on a low protein diet during pregnancy. Diabetes. 1991;40(suppl 2):115-121
14. Dahri S, Cherif H, Reusens B, Remacle C, Hoet JJ. Effect of an isolcaloric low protein diet during gestation in rat on in vitro insulin secretion by islets of the offspring. Diabetologia. 1994;37(suppl 1):A80
15. Rasschaert J, Reusens B, Dahri S, et al. Impaired activity of rat pancreatic islet mitochondrial glycerophosphate dehydrogenase in protein malnutrition. Endocrinology. 1995;136:2631-2634
16. Chard T, Yoong A, Macintosh M. The myth of fetal growth retardation at term. Br J Obstet Gynaecol. 1993;100:1076-1981
17. Chard T, Costeloe K, Leaf A. Evidence of growth retardation in neonates of apparently normal weight. Eur J Obstet Gynecol Reprod Endocrinol. 1992;45:59-62
18. Cliver SP, Goldenberg RL, Cutter GR, Hoffman HJ, Davis RO, Nelson KG. The effect of cigarette smoking on neonatal anthropométrie measurements. Obstet Gynecol. 1995;85:635-630
19. Goldenberg RL, Hauth JC, DuBard MB, Copper RL, Cutter GR. Fetal growth in women using low-dose aspirin for the prevention of preeclampsia: effect of maternal size J Maternal Fetal Med. 1995;4: 218-222
20. Goldenberg RL, Cliver SP, Cutter GR, Davis RO, Hoffman HJ, Wen SW. Blood pressure, growth retardation, and preterm delivery. Int J Tech Assess Health Care. 1992;8(suppl):82-90
21. Goldenberg RL, Tamura T, Neggers Y, et al. The effect of zinc supplementation on pregnancy outcome. JAMA. 1995;274:463-468
22. Hawdon JM, Hey E, Kolvin I, Fundudis T. Born too small-is out come still affected? Dev Med Child Neural. 1990;32:943-953
23. Smeriglio VL. Developmental sequelae following intrauterine growth retardation. In: Gross TL, Sokol RJ, eds. Intrauterine Growth Retardation: A Practical Approach. Chicago, IL: Year Book Medical Publishers; 1989
24. Fanaroff AA, Wright LL, Stevenson DK, et al. Very-low-birth-weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, May 1991 through December 1992. Am l Obstet Gynecol. 1995;173:1423-1432
25. Low JA, Handley-Derry MH, Burke SO, et al. Association of intrauterine fetal growth retardation and learning deficits at age 9 to 11 years. Am l Obstet Gynecol. 1992;167:1499-1505
26. Walther FJ. Growth and development of term disproportionate smallfor-gestational age infants at the age of 7 years. Early Hum Dev. 1988; 18:1-11
27. Harvey D, Prince J, Burton J, Parkinson C, Campbell S. Abilities of children who were small-for-gestational-age babies. Pediatrics. 1982;69: 296-300
28. Parkinson CE, Wallis S, Harvey D. School achievement and behavior of children who were small-for-dates at birth. Dev Med Chilli Neural. 1981; 23:41-50
29. Blair E, Stanley F. Intrauterine growth and spastic cerebral palsy. I. Association with birth weight for gestational age. Am J Obstet Gynecol. 1990;l 62:229-237
30. Kramer MS, Oliver M, McLean FH, Willis DM, Usher RH. Impact of intrauterine growth retardation and body proportionality on fetal and neonatal outcome. Pediatrics. 1990;85:707-713
31. Hadders-Algra M, Touwen BCL. Body measurements, neurological and behavioral development in six-year-old children born preterm and/or small-for-gestational-age. Early Hum Dev. 1991;22:1-13
32. Hack M, Breslau N, Fanaroff AA. Differential effects of intrauterine and postnatal brain growth failure in infants of very low birth weight. Am J Dis Child. 1989;l 3:63-68
33. Pena 1C, Teberg AC, Finello KM. The premature small-for-gestationalage infant during the first year of life: comparison by birth weight and gestational age J Pediatr. 1988;113:1066-1073
34. Sung I-K, Vohr B, Oh W. Growth and neurodevelopmental outcome of very low birth weight infants with intrauterine growth retardation: comparison with control subjects matched by birth weight and gestational age J Pediatr. 1993;123:618-624
35. Mathews LS, Hammer RE, Behringer RR, et al. Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology. 1988;2827-2833
36. Behringer RR, Lewin TM, Quaife CJ, Palmiter RD, Brinster RL, D'Ercole AJ. Expression of Insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice. Endocrinology. 1990;127:1033-1040
37. D'Ercole AJ, Dai Z, Xing Y, et al. Brain growth retardation due to the expression of human insulin like growth factor binding protein 1 (IGFBP-1) in transgenic mice: an in vivo model for the analysis of IGF function in the brain. Dev Brain Res. 1994;82:213-222
38. Ye P, Carson J, D'Ercole AJ. In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice J Neurosci. 1995;15:7344-7356
39. Delhanty PJD, Han VKM. The expression of insulin-like growth factor (IGF)-binding protein-2 and IGF-II genes in the tissues of the developing ovine fetus. Endocrinology. 1993;l 32:41 -52
40. Wood TL, Regler L, Streck RD, et al. Targeted disruption of IGFBP-2 gene. Growth Regul. 1993;3:3-6
41. Pintar JE, Wood TL, Streck RD, Havton L, Rogler L, Hsu MS. Expression of IGF-II, the IGF-II/mannose-6-phosphate receptor and IGFBP-2 during rat embryogenesis. Adv Exp Med biol. 1991;293:325-333
42. Wood TL, Streck RD, Pintar JE. Expression of the IGFBP-2 gene in post-implantation rat embryos. Development. 1992;114:59-66
43. Crystal RA, Giduice LC. Insulin-like growth factor binding protein (IGFBP) profiles in human fetal cord sera: ontogeny during gestation and differences in newborns with intrauterine growth retardation (IUGR) and large for gestational age (LGA) newborns. In: Spencer EM, ed. Modern Concepts of Insulin-Eikc Growth Factors. New York, NY: Elsevier; 1991:395-408
44. Brenneman DE, Eiden LE. Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc Natl Acad Sci USA. 1986;83: 1159-1162
45. Hill JM, Agoston DV, Gressens P, McCune SK. Distribution of VIP mRNA and two distinct VIP binding sites in the developing brain; relation to ontogenic events J Comp Neural. 1994;342:186-205
46. Gressens P, Hill JM, Gozes I, Fridkin M, Brenneman DE. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature (Land). 1993;362:155-158
47. Gressens P, Hill JM, Paindaveine B, Gozes I, Fridkin M, Brenneman DE. Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse J Clin Invest. 1994;94:2020-2027
48. Hill JM, McCune SK, Alvero RJ, et al. Maternal vasoactive intestinal peptide and the regulation of embryonic growth in the rodent J Clin Invest. 1996;97:202-208
49. Damsky CH, Fitzgerald ML, Fisher SJ. Distribution of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo J Clin Invest. 1992;89:210-222
50. Damsky CH, Librach C, Lim K-H, et al. Integrin switching regulates normal trophoblast invasion. Development. 1994;l 20:3657-3666
51. Zhou Y, Damsky CH, Chiu K, Roberts JM, Fisher SJ. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts J Clin Invest. 1993;91:950-960
52. Genbacev O, Joslin RJ, Damsky CH, Polliotto BM, Fisher SJ. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia J Clin Invest. 1996;97:540-550
53. Handwerger S. The physiology of placental lactogen in human pregnancy. Endocr Rev. 1992;12:329-336
54. Freemark M, Handwerger S. The role of placental lactogen in the regulation of fetal metabolism J Pediatr Gastroenterol Nutr. 1989;8: 281-287
55. Handwerger S, Richards R, Myers S. Novel regulation of the synthesis and release of human placental lactogen by high density lipoproteins-a review. Trophoblast Res. 1994;8:339-354
56. Gluckman PD. The endocrine regulation of fetal growth in late gestation-the role of insulin like growth factors J Clin Endocrinol Metab. 1995;80:1047-1050
57. Oliver MH, Harding JE, Breier BH, Evans PC. Glucose but not a mixed amino acid infusion regulates plasma IGF-I concentrations in fetal sheep. Pediatr Res. 1993;34:62-65
58. Harding JE, Liu L, Evans PC, Gluckman PD. IGF-I alters feto-placental protein and carbohydrate metabolism in fetal sheep. Endocrinology. 1994;134:1509-1515
59. Liu L, Harding JE, Evans PC, Gluckman PD. Maternal IGF-I infusion alters fetal-placental carbohydrate and protein metabolism in pregnant sheep. Endocrinology. 1994;135:895-900
60. Marconi AM, Ferrazzi E, Cetin I, Lanfranchi A, Pardi G, Battaglia FC. Umbilical velocimetry differentiates growth retarded fetuses at risk of acidemia. Third Congress of the International Perinatal Doppler Society, Los Angeles, CA, 1990
61. Cetin 1, Marconi AM, Baggiani AM, et al. In vivo placental transport of glycine and leucine in human pregnancies. Pediatr Res. 1995;37:571-575
62. Marconi AM, Ferrazzi E, Cetin I, Ferrari MM, Pardi G, Battaglia FC. Lactate metabolism in normal and growth retarded human fetuses. Pediatr Res. 1990;28:652-656
63. Pardi G, Cetin 1, Marconi AM, et al. Diagnostic value of blood sampling in fetuses with growth retardation. N Engl JMed. 1993;328:692-696
64. Pardi G, Cetin I, Marconi AM, et al. Venous drainage of the human uterus: respiratory gas studies in normal and fetal growth-retarded pregnancies. Am J Obstet Gynecol. 1992;166:699-706
65. Pardi G, Cetin I, Marconi AM, et al. The role of fetal blood sampling in relation to fetal heart rate and Doppler velocimetry in growth retarded fetuses. Soc Gynecol Invest. 1993;Abstract #P220
66. Richards DS. The fetal vibroacoustic stimulation test: an update. Semin Perinatal. 1990;14:305-310
67. Charlton V, Johengen M. Effects of intrauterine nutritional supplementation on fetal growth retardation. Biol Neonate. 1985;48:125-142
68. Padbury JF, Ervin MG, Polk DH. Extrapulmonary effects of antenatally administered steroids J Pediatr. 1996;128:167-172
69. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for the prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972;50:515-525
70. Ikegami M, Polk D, Tabor B, Lewis J, Yamada T, Jobe AH. Corticosteroid and thyrotropin-releasing hormone effects on preterm sheep lung function J Appl Physiol. 1991;70:2268-2278